In a media event held June 18, two of the world's most acclaimed cancer researchers, Drs. Tak Mak of the Princess Margaret Cancer Centre, and Dennis Slamon of the University of California, Los Angeles, shared news of a major breakthrough in their decade-long pursuit to develop a new class of "sharpshooter" cancer drugs.

The Canada Foundation for Innovation announced the results of the most recent Leaders Opportunity Fund competition; the awardees include TGRI’s Drs. Michael Wheeler, Daniel Winer and Minna Woo. Funding will help establish a new Diabetes Discovery Core, which will use state-of-the-art equipment to examine the role of metabolism, inflammation and other cellular stress in beta cells and other metabolic tissues implicated in diabetes. This research will help develop new methods for treating this disease.

OCI Senior Scientist Dr. Alex Vitkin was recently named a Fellow of the Society of Photo-Optical Instrumentation Engineers in recognition of his considerable scientific and technical contributions to the fields of biomedical optics and biophotonics.  His research has contributed significantly to the development and use of optical coherence tomography to monitor treatment responses to photodynamic and radiation therapies, a unique imaging approach that fits well within the emerging trend of personalized medicine.